Virginia has seen a 31.6 percent decrease of long-stay nursing center residents receiving antipsychotic medications since the fourth quarter of 2011.  Nationally, there has been a 31.8 decrease over the same period.  Virginia ranks 22^nd among all states on the prevalence of antipsychotic use for long-stay residents for the second quarter of 2016.

In the fourth quarter of 2011, 23.9 percent of long-stay nursing home residents received an antipsychotic medication; since then there has been a decrease of 31.8 percent to a national prevalence of 16.3 percent in second quarter of 2016. Success varies by state and CMS region; some states and regions have seen a reduction greater than 30 percent.

CMS is tracking the progress of the National Partnership to Improve Dementia Care in Nursing Homes by reviewing publicly reported measures. The official measure is the percentage of long-stay nursing home residents who receive an antipsychotic medication, excluding residents diagnosed with schizophrenia, Huntington’s disease, or Tourette’s syndrome.

For more information, visit the National Partnership webpage or join the upcoming CMS call.

CMS National Partnership to Improve Dementia Care and QAPI Call
December 6, 2016 | 1:30 pm – 3:00 pm